Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth

被引:22
作者
Eskiocak, Ugur [1 ]
Kim, Sang Bum [1 ]
Ly, Peter [1 ]
Roig, Andres I. [1 ,2 ]
Biglione, Sebastian [1 ]
Komurov, Kakajan [3 ]
Cornelius, Crystal [1 ]
Wright, Woodring E. [1 ]
White, Michael A. [1 ]
Shay, Jerry W. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
关键词
TUMOR SUPPRESSORS; GENETIC SCREEN; HUMAN BREAST; CELLS; RAS; P53;
D O I
10.1158/0008-5472.CAN-11-0794
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Landmark cancer genome resequencing efforts are leading to the identification of mutated genes in many types of cancer. The extreme diversity of mutations being detected presents significant challenges to subdivide causal from coincidental mutations to elucidate how disrupted regulatory networks drive cancer processes. Given that a common early perturbation in solid tumor initiation is bypass of matrix-dependent proliferation restraints, we sought to functionally interrogate colorectal cancer candidate genes ( CAN-genes) to identify driver tumor suppressors. We have employed an isogenic human colonic epithelial cell ( HCEC) model to identify suppressors of anchorage-independent growth by conducting a soft agar-based short hairpin RNA (shRNA) screen within the cohort of CAN-genes. Remarkably, depletion of 65 of the 151 CAN-genes tested collaborated with ectopic expression of K-RAS(V12) and/or TP53 knockdown to promote anchorage-independent proliferation of HCECs. In contrast, only 5 of 362 random shRNAs (1.4%) enhanced soft agar growth. We have identified additional members of an extensive gene network specifying matrix-dependent proliferation, by constructing an interaction map of these confirmed progression suppressors with approximately 700 mutated genes that were excluded from CAN-genes, and experimentally verifying soft agar growth enhancement in response to depletion of a subset of these genes. Collectively, this study revealed a profound diversity of nodes within a fundamental tumor suppressor network that are susceptible to perturbation leading to enhanced cell-autonomous anchorage-independent proliferative fitness. Tumor suppressor network fragility as a paradigm within this and other regulatory systems perturbed in cancer could, in large part, account for the heterogeneity of somatic mutations detected in tumors. Cancer Res; 71( 13); 4359-65. (C) 2011 AACR.
引用
收藏
页码:4359 / 4365
页数:7
相关论文
共 20 条
[1]   The functional contrariety of JNK [J].
Bode, Ann M. ;
Dong, Zigang .
MOLECULAR CARCINOGENESIS, 2007, 46 (08) :591-598
[2]   Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model [J].
Bric, Anka ;
Miething, Cornelius ;
Bialucha, Carl Uli ;
Scuoppo, Claudio ;
Zender, Lars ;
Krasnitz, Alexander ;
Xuan, Zhenyu ;
Zuber, Johannes ;
Wigler, Michael ;
Hicks, James ;
McCombie, Richard W. ;
Hemann, Michael T. ;
Hannon, Gregory J. ;
Powers, Scott ;
Lowe, Scott W. .
CANCER CELL, 2009, 16 (04) :324-335
[3]   Cancer-Specific High-Throughput Annotation of Somatic Mutations: Computational Prediction of Driver Missense Mutations [J].
Carter, Hannah ;
Chen, Sining ;
Isik, Leyla ;
Tyekucheva, Svitlana ;
Velculescu, Victor E. ;
Kinzler, Kenneth W. ;
Vogelstein, Bert ;
Karchin, Rachel .
CANCER RESEARCH, 2009, 69 (16) :6660-6667
[4]   Anoikis: A necessary death program for anchorage-dependent cells [J].
Chiarugi, Paola ;
Giannoni, Elisa .
BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1352-1364
[5]   CDDO-Me Protects against Space Radiation-Induced Transformation of Human Colon Epithelial Cells [J].
Eskiocak, Ugur ;
Kim, Sang Bum ;
Roig, Andres I. ;
Kitten, Erin ;
Batten, Kimberly ;
Cornelius, Crystal ;
Zou, Ying S. ;
Wright, Woodring E. ;
Shay, Jerry W. .
RADIATION RESEARCH, 2010, 174 (01) :27-36
[6]   Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells [J].
Hiatt, KK ;
Ingram, DA ;
Zhang, YY ;
Bollag, G ;
Clapp, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (10) :7240-7245
[7]   A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity [J].
Kolfschoten, IGM ;
van Leeuwen, B ;
Berns, K ;
Mullenders, J ;
Beijersbergen, RL ;
Bernards, R ;
Voorhoeve, PM ;
Agami, R .
CELL, 2005, 121 (06) :849-858
[8]   The CANCER GENOME challenge [J].
Ledford, Heidi .
NATURE, 2010, 464 (7291) :972-974
[9]   An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB [J].
Min, Junxia ;
Zaslavsky, Alexander ;
Fedele, Giuseppe ;
McLaughlin, Sara K. ;
Reczek, Elizabeth E. ;
De Raedt, Thomas ;
Guney, Isil ;
Strochlic, David E. ;
MacConaill, Laura E. ;
Beroukhim, Rameen ;
Bronson, Roderick T. ;
Ryeom, Sandra ;
Hahn, William C. ;
Loda, Massimo ;
Cichowski, Karen .
NATURE MEDICINE, 2010, 16 (03) :286-U82
[10]   Opposing effects of Ras on p53:: Transcriptional activation of mdm2 and induction of p19ARF [J].
Ries, S ;
Biederer, C ;
Woods, D ;
Shifman, O ;
Shirasawa, S ;
Sasazuki, T ;
McMahon, M ;
Oren, M ;
McCormick, F .
CELL, 2000, 103 (02) :321-330